Business Description

Description
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
Name Current Vs Industry Vs History
Cash-To-Debt 0.55
Equity-to-Asset -0.02
Debt-to-Equity -37.54
Debt-to-EBITDA -0.18
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 18.61
9-Day RSI 24.25
14-Day RSI 30.41
6-1 Month Momentum % -73.22
12-1 Month Momentum % -83.96

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.51
Quick Ratio 0.51
Cash Ratio 0.35

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -92.18
Name Current Vs Industry Vs History
ROE % -1727.92
ROA % -235.39
ROIC % -227.27
ROC (Joel Greenblatt) % -561.11
ROCE % -1240.62

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.28
EV-to-Forward-EBIT 0.46
EV-to-EBITDA -0.29
EV-to-FCF -0.34
Earnings Yield (Greenblatt) % -357.14
FCF Yield % -404.13

Financials

CING's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CING

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cingulate Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -32.6
Beta 0
Volatility % 140.97
14-Day RSI 30.41
14-Day ATR ($) 0.427906
20-Day SMA ($) 1.573495
12-1 Month Momentum % -83.96
52-Week Range ($) 1 - 38.6
Shares Outstanding (Mil) 3.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cingulate Inc Filings

Filing Date Document Date Form
No Filing Data

Cingulate Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cingulate Inc Frequently Asked Questions

What is Cingulate Inc(CING)'s stock price today?
The current price of CING is $1.04. The 52 week high of CING is $38.60 and 52 week low is $1.00.
When is next earnings date of Cingulate Inc(CING)?
The next earnings date of Cingulate Inc(CING) is .
Does Cingulate Inc(CING) pay dividends? If so, how much?
Cingulate Inc(CING) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1